tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
Melanoma, Melanoma Skin Cancer: Click to Expand ⟱
Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vivo, |
Melanoma, |
SK-MEL-28 |
|
|
|
- |
in-vivo, |
Melanoma, |
WM35 |
|
|
|
ROS↑, Ca+2↝, Casp3↑, Casp8↑, Casp9↑, CD4+↑, CD8+↑, tumCV↓, eff↓, *toxicity↓,
| - |
in-vitro, |
Melanoma, |
A2780S |
|
|
|
tumCV↓, sonoP↑, BioEnh↑,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
AntiCan↑, eff↓, ChemoSen↑, ER Stress↑, tumCV↓, DNAdam↑, GSH∅, HSP70/HSPA5↓, UPR↑, β-catenin/ZEB1↓, ROS↑, HO-2↑, SIRT1↑, GlucoseCon∅, lactateProd∅, chemoP↑,
| - |
vitro+vivo, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2058 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-7951 |
|
|
|
TumCG↓, Apoptosis↑, PD-L1↓, STAT1↓, tumCV↓, T-Cell↑,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
tumCV↓, Apoptosis↑, BAX↑, Cyt‑c↑, Bcl-2↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
B16-F10 |
|
|
|
ROS↑, eff↓, tumCV↓, Casp3↑, necrosis↑,
tumCV↓, selectivity↑, MPT↑, Cyt‑c↑, Casp3↑, Casp9↑, Apoptosis↑, mtDam↑, chemoPv↑,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
tumCV↓, Apoptosis↑, ROS↑, p66Shc↑,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Colon, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
tumCV↓,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
tumCV↓, TumCCA↑, ROS↑, eff↑,
tumCV↓, Apoptosis↑, P53↑, γH2AX↑, Akt↓, ROS↑, DNAdam↑,
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
tumCV↓, GSH↓, MDA↑, ROS↑, Apoptosis↑,
| - |
in-vitro, |
Melanoma, |
B16-BL6 |
|
|
|
tumCV↓, ROS↑, mtDam↑,
| - |
in-vivo, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
*cl‑Casp8↑, *PARP↑, *P21↑, tumCV↓, TumCP↓, TumCCA↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK4↓, CDC2↓, P21↑, Apoptosis↑,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Melanoma, |
WM983B |
|
|
|
tumCV↓, ROS↑, antiOx↑, Apoptosis↑, BAX↑, P53↑, Casp3↑, Casp9↑,
tumCV↓, MMP↓, Casp3↑, Thiols↝,
| - |
in-vitro, |
Melanoma, |
A2058 |
|
|
|
- |
in-vitro, |
Nor, |
L929 |
|
|
|
tumCV↓, selectivity?, ROS?, BAX↑, TumCCA?, MMP2↓, MMP9↓, TumCMig↓, eff↑,
| - |
in-vitro, |
Melanoma, |
MSTO-211H |
|
|
|
tumCV↓, Apoptosis↑, Sp1/3/4↓, p27↓, P21↓, cycD1/CCND1↓, Mcl-1↓, survivin↓,
| - |
in-vitro, |
Melanoma, |
SK-MEL-28 |
|
|
|
tumCV↓, TumCMig↓, ROS↓, Casp3↑, selectivity↑, Casp8↑, NLRP3↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
tumCV↓, selectivity↑, ROS↑, MMP↓, Apoptosis↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓,
Showing Research Papers: 1 to 20 of 20
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 20
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GSH↓, 1, GSH∅, 1, HO-2↑, 1, MDA↑, 1, p66Shc↑, 1, ROS?, 1, ROS↓, 1, ROS↑, 11, Thiols↝, 1,
Mitochondria & Bioenergetics ⓘ
CDC2↓, 1, MMP↓, 2, MPT↑, 1, mtDam↑, 2,
Core Metabolism/Glycolysis ⓘ
GlucoseCon∅, 1, lactateProd∅, 1, SIRT1↑, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 10, BAX↑, 4, Bcl-2↓, 2, Casp3↑, 7, cl‑Casp3↑, 1, Casp8↑, 2, Casp9↑, 4, cl‑Casp9↑, 1, Cyt‑c↑, 2, Mcl-1↓, 1, necrosis↑, 1, p27↓, 1, survivin↓, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 20,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1, HSP70/HSPA5↓, 1, UPR↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2, P53↑, 2, cl‑PARP↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 1, P21↓, 1, P21↑, 1, TumCCA?, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
STAT1↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2↝, 1, MMP2↓, 1, MMP9↓, 1, TumCMig↓, 2, TumCP↓, 1, β-catenin/ZEB1↓, 1,
Barriers & Transport ⓘ
sonoP↑, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, PD-L1↓, 1, T-Cell↑, 1,
Protein Aggregation ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
BioEnh↑, 1, ChemoSen↑, 1, eff↓, 4, eff↑, 2, selectivity?, 1, selectivity↑, 3,
Clinical Biomarkers ⓘ
PD-L1↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, chemoP↑, 1, chemoPv↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 72
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
cl‑Casp8↑, 1,
DNA Damage & Repair ⓘ
PARP↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 4
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page